Related Experiment Video
Updated: Mar 16, 2026

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
Published on: April 30, 2020
Mortality in smear-negative tuberculosis patients in Phalombe
Jcj Calis1, M L Bakker1, R B Elens2
1Academic Medical Center, University of Amsterdam, Netherlands.
High mortality was observed in smear-negative pulmonary tuberculosis patients in Malawi. Those with normal chest x-rays (CXR) or low white cell counts faced particularly high death rates, warranting further investigation.
Area of Science:
- Global Health
- Infectious Diseases
- Pulmonology
Background:
- Tuberculosis (TB) remains a significant global health challenge, particularly in regions with high Human Immunodeficiency Virus (HIV) prevalence.
- Smear-negative pulmonary tuberculosis (PTB) presents diagnostic difficulties and is associated with poorer outcomes.
- Malawi faces a dual epidemic of HIV and TB, with 80-90% HIV prevalence among TB patients.
Purpose of the Study:
- To determine the treatment outcomes for patients with smear-negative pulmonary tuberculosis in Malawi.
- To investigate the relationship between chest x-ray (CXR) findings, laboratory parameters, and mortality in this patient group.
Main Methods:
- Retrospective analysis of 70 patients registered with smear-negative PTB across two Malawian hospitals.
- Evaluation of treatment outcomes, including mortality rates.
- Correlation of outcomes with CXR findings and white cell count.
Main Results:
- A high mortality rate of 46% (32 out of 70 patients) was recorded.
- Mortality was significantly higher in patients with normal or minimally abnormal CXR findings (62%).
- Patients with a white cell count below 3.5 × 10^9/L experienced a 77% mortality rate.
Conclusions:
- Smear-negative pulmonary tuberculosis in high HIV prevalence settings is associated with extremely poor treatment outcomes.
- Normal chest x-ray findings and low white cell counts are indicators of particularly high mortality risk.
- Further research is crucial to understand the underlying reasons for this high mortality and to develop targeted interventions.
More Related Videos
09:02An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
Published on: February 17, 2014
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...